{"id":245437,"date":"2011-04-16T17:11:47","date_gmt":"2011-04-16T17:11:47","guid":{"rendered":"http:\/\/eugenesis.com\/molecular-pathology-laboratory-network-inc-selects-mscope-clinical-for-its-pathology-imaging-communications-integration-platform\/"},"modified":"2011-04-16T17:11:47","modified_gmt":"2011-04-16T17:11:47","slug":"molecular-pathology-laboratory-network-inc-selects-mscope-clinical-for-its-pathology-imaging-communications-integration-platform","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/molecular-pathology-laboratory-network-inc-selects-mscope-clinical-for-its-pathology-imaging-communications-integration-platform.php","title":{"rendered":"Molecular Pathology Laboratory Network, Inc. Selects mScope Clinical For Its Pathology Imaging Communications &#038; Integration Platform"},"content":{"rendered":"<div><p><strong><span><br>This new partnership signifies a major breakthrough with a market&nbsp;<\/span><span>leader in Comprehensive, Personalized Testing Services<\/span><\/strong><\/p><p><span>MONTREAL (CANADA), April 13, 2011 &ndash; Aurora Interactive Ltd., a world leader in digital&nbsp;<\/span><span>pathology communications announced today that the company has signed a license agreement&nbsp;<\/span><span>for its mScope Clinical communications and imaging modalities integration platform with&nbsp;<\/span><span>Molecular Pathology Laboratory Network, Inc. (MPLN), a leader in specialized reference&nbsp;<\/span><span>laboratory services dedicated to providing superior diagnostic testing and complementary&nbsp;<\/span><span>technologies, including molecular diagnostics, flow cytometry, fluorescence in situ hybridization,<\/span><span>immunohistochemistry and cytogenetics.<\/span><\/p><p><span>&ldquo;We chose Aurora for their cost efficient plug-and-play and proven integration solution. Given the&nbsp;<\/span><span>variety of imaging modalities we use, we considered Aurora&rsquo;s universality key to maintaining our&nbsp;<\/span><span>strategic flexibility and creating a common user interface for our internal and external clients,&rdquo;&nbsp;<\/span><span>said Steve Olsen, MS, HTL (ASCP), Chief Operating Officer of MPLN.<\/span><\/p><p><span>&ldquo;We are very excited about MPLN&rsquo;s decision to partner with Aurora. MPLN is a cutting edge&nbsp;<\/span><span>provider who is dedicated to client service and making a difference in patient care. We are proud&nbsp;<\/span><span>they chose us as their communications and integration partner&rdquo; stated Pierre Le F&egrave;vre, President&nbsp;<\/span><span>and Chief Executive Officer, Aurora Interactive.<\/span><\/p><p><span>About Aurora Interactive Ltd.<\/span><\/p><p><span>Aurora Interactive has developed the leading web based software platform (mScope) for&nbsp;<\/span><span>simplification, productivity and ease of communications in digital pathology. mScope&rsquo;s Universal&nbsp;<\/span><span>Web Viewer has collaborative tools to view medical slides and images anytime, anywhere,&nbsp;<\/span><span>regardless of file format. The software has four applications to meet digital pathology&nbsp;<\/span><span>communications needs: mScope Education, mScope Clinical, mScope Research and mScope&nbsp;<\/span><span>Universal Viewer. Aurora&rsquo;s mission is to improve patient outcomes and help members of the&nbsp;<\/span><span>medical community achieve their full potential by eliminating the learning, diagnostic and&nbsp;<\/span><span>collaborative restrictions imposed by time and space. <a href=\"http:\/\/www.aurorainteractive.com\" target=\"_blank\">http:\/\/www.aurorainteractive.com<\/a>.<\/span><\/p><p><span>About Molecular Pathology Laboratory Network, Inc.<\/span><\/p><p><span>Molecular Pathology Laboratory Network, Inc. (MPLN) is a privately-owned regional reference&nbsp;<\/span><span>laboratory founded in 1989 with headquarters in Maryville, Tenn. and a satellite laboratory in&nbsp;<\/span><span>Richmond, Va. A leader in personalized laboratory medicine, MPLN specializes in oncology and&nbsp;<\/span><span>women&rsquo;s health testing and has extensive expertise in chromosome analysis, flow cytometry,&nbsp;<\/span><span>fluorescence in situ hybridization (FISH), real-time and quantitative polymerase chain reaction&nbsp;<\/span><span>technologies, anatomic pathology, immunohistochemistry and gene sequencing. The laboratory&nbsp;<\/span><span>also offers research and development services through its clinical trial division, Geneuity Clinical&nbsp;<\/span><span>Research Services. MPLN is certified by the Clinical Laboratory Improvement Amendments&nbsp;<\/span><span>(CLIA), accredited by the College of American Pathologists (CAP), and licensed by the states of&nbsp;<\/span><span>Tennessee, Florida, New York and Maryland. For more information about MPLN, visit&nbsp;<\/span><span><a href=\"http:\/\/www.mplnet.com\" target=\"_blank\">http:\/\/www.mplnet.com<\/a>.<\/span><\/p><p><span><span><br><\/span><\/span><\/p><\/div><div><a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=BfjzERxdgYk:mZ9ZZr_63wE:yIl2AUoC8zA\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/15ad6_DigitalPathologyBlog?d=yIl2AUoC8zA\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=BfjzERxdgYk:mZ9ZZr_63wE:F7zBnMyn0Lo\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/15ad6_DigitalPathologyBlog?i=BfjzERxdgYk:mZ9ZZr_63wE:F7zBnMyn0Lo\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=BfjzERxdgYk:mZ9ZZr_63wE:7Q72WNTAKBA\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/15ad6_DigitalPathologyBlog?d=7Q72WNTAKBA\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=BfjzERxdgYk:mZ9ZZr_63wE:V_sGLiPBpWU\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/15ad6_DigitalPathologyBlog?i=BfjzERxdgYk:mZ9ZZr_63wE:V_sGLiPBpWU\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=BfjzERxdgYk:mZ9ZZr_63wE:qj6IDK7rITs\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/15ad6_DigitalPathologyBlog?d=qj6IDK7rITs\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=BfjzERxdgYk:mZ9ZZr_63wE:l6gmwiTKsz0\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/15ad6_DigitalPathologyBlog?d=l6gmwiTKsz0\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=BfjzERxdgYk:mZ9ZZr_63wE:gIN9vFwOqvQ\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/15ad6_DigitalPathologyBlog?i=BfjzERxdgYk:mZ9ZZr_63wE:gIN9vFwOqvQ\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a> <a href=\"http:\/\/feeds.feedburner.com\/~ff\/DigitalPathologyBlog?a=BfjzERxdgYk:mZ9ZZr_63wE:TzevzKxY174\"><img decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/6b4d7_DigitalPathologyBlog?d=TzevzKxY174\" border=\"0\" style=\"padding-left:10px; padding-right: 10px;\"><\/a><\/div><p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/eugenesis.com\/wp-content\/plugins\/wp-o-matic\/cache\/6b4d7_BfjzERxdgYk\" height=\"1\" width=\"1\" style=\"padding-left:10px; padding-right: 10px;\"><\/p>","protected":false},"excerpt":{"rendered":"<p>This new partnership signifies a major breakthrough with a market&nbsp;leader in Comprehensive, Personalized Testing ServicesMONTREAL (CANADA), April 13, 2011 &ndash; Aurora Interactive Ltd., a world leader in digital&nbsp;pathology communications announced today that the company has signed a license agreement&nbsp;for its &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/pathology\/molecular-pathology-laboratory-network-inc-selects-mscope-clinical-for-its-pathology-imaging-communications-integration-platform.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577487],"tags":[],"class_list":["post-245437","post","type-post","status-publish","format-standard","hentry","category-pathology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245437"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=245437"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/245437\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=245437"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=245437"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=245437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}